Status:
COMPLETED
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
Lead Sponsor:
Gynuity Health Projects
Conditions:
Termination of Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outs...
Detailed Description
This study will investigate the uptake of mifepristone administration outside of the health center for pregnancy termination and its acceptability to women and to their providers. In addition, we plan...
Eligibility Criteria
Inclusion
- Women 18 years and older
- seeking medical abortion services
- in general good health
- assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken
- eligible for medical abortion according to clinician and center standards.
Exclusion
- will be followed up by beta HCG and not ultrasound
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT01811056
Start Date
April 1 2013
End Date
July 1 2014
Last Update
August 13 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood of New York City
New York, New York, United States
2
Planned Parenthood of Northern New England
Barre, Burlington, Rutland, Vermont, United States
3
Planned Parenthood of the Great Northwest
Seattle, Washington, United States